Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes

<div>Expected changes in natural killer (NK) cell function and count after the preoperative or “preventive” infusion of expanded allogeneic or autologous NK cells (NKTT).</div>

Scientifica

fig3

Figure 3

Figure 3: Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes 